BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6602775)

  • 1. Inhibition of T gamma rosette formation by the sera from patients with systemic lupus erythematosus. Relation to T gamma-specific antilymphocyte antibody.
    Okudaira K; Tanimoto K
    Int Arch Allergy Appl Immunol; 1983; 71(4):346-51. PubMed ID: 6602775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc-rosette inhibition by hypocomplementaemic systemic lupus erythematosus sera.
    Morito T; Tanimoto K; Hashimoto Y; Horiuchi Y; Juji T
    Ann Rheum Dis; 1975 Oct; 35(5):415-21. PubMed ID: 1086653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
    Nakai H; Morito T; Tanimoto K; Horiuchi Y
    J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of antilymphocyte antibody in SLE and its correlation with disease activity.
    Okudaira K; Tanimoto K; Aikawa T; Horiuchi Y; Aotsuka S
    Scand J Rheumatol; 1983; 12(1):21-8. PubMed ID: 6601298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
    Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
    J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a sheep anti-pig T lymphoblast serum with specificity for E rosette-forming lymphocytes.
    Licence ST; Binns RM
    Vet Immunol Immunopathol; 1984 Oct; 7(3-4):255-73. PubMed ID: 6334394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte rosette inhibition as an assay for naturally occurring T lymphocytotoxic antibody in systemic lupus erythematosus.
    Koike T; Kobayashi S; Yoshiki T; Itoh T; Shirai T
    Arthritis Rheum; 1979 Oct; 22(10):1064-73. PubMed ID: 314803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T gamma subset specificity of lymphocyte reactive factors in juvenile rheumatoid arthritis and systemic lupus erythematosus sera.
    Williams RC; Froelich CJ; Kilpatrick K; Crowe WE; Levinson JE
    Arthritis Rheum; 1981 Apr; 24(4):585-91. PubMed ID: 6971106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface antigen specificity of cold-reactive IgM antilymphocyte antibodies in systemic lupus erythematosus.
    Yamada A; Shaw M; Winfield JB
    Arthritis Rheum; 1985 Jan; 28(1):44-51. PubMed ID: 2578282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.
    Goto M; Tanimoto K; Horiuchi Y
    Arthritis Rheum; 1980 Nov; 23(11):1274-81. PubMed ID: 6969594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of anti-beta 2-microglobulin antibodies to T11 and T-cell activation in systemic lupus erythematosus.
    Croghan TW; Minota S; Yamada A; Winfield JB
    Clin Immunol Immunopathol; 1985 Nov; 37(2):179-90. PubMed ID: 3899432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. A corollary of disease activity.
    Scheinberg MA; Israel Filho G; Mendes NF; Vertzman L
    J Rheumatol; 1978; 5(1):19-25. PubMed ID: 305960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasmapheresis on E-rosette receptors in SLE patients.
    Vangelista A; FrascĂ  GM; Nanni-Costa A; Bonomini V
    J Clin Apher; 1986; 3(2):100-2. PubMed ID: 3084456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
    Minota S; Winfield JB
    J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed rosette assay for the detection of T mu and T gamma lymphocytes.
    Cnossen J; Lafeber GJ; Damsteeg WJ; Meijer CJ
    J Immunol Methods; 1980; 36(3-4):197-209. PubMed ID: 6968798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus.
    Mahowald ML; Dalmasso AP
    Ann Rheum Dis; 1982 Dec; 41(6):593-8. PubMed ID: 7149796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the lymphocytotoxic activity found in sera from patients with hypogammaglobulinaemia.
    MacDonald S; Webster AD; Platts-Mills TA
    Scand J Immunol; 1982 Apr; 15(4):379-87. PubMed ID: 6980448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous rosette formation in systemic lupus erythematosus.
    Bodolay E; Szegedi G
    Acta Med Hung; 1983; 40(2-3):81-9. PubMed ID: 6608094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.